Literature DB >> 89343

Changing pattern of schistosomiasis in Egypt 1935--79.

M F Abdel-Wahab, G T Strickland, A El-Sahly, N El-Kady, S Zakaria, L Ahmed.   

Abstract

A village in the Nile surveyed for schistosomiasis by J. A. Scott in 1935 was surveyed again in 1979. The same number of people as in the 1935 survey were randomly selected for investigation by the same parasitological techniques as those used by Scott. The prevalence of Schistosoma mansoni infection had increased from 3.2% to 73%, whereas S. haematobium infection, which had been very common in 1935 (74%), had almost disappeared (2.2%). In the local district hospital since 1972 the percentage of urine specimens found to contain S. haematobium ova has dropped from 30 to 9%, while the percentage of stool specimens containing S. mansoni ova has increased from 2 to 22%. In the local irrigation canals snail intermediate hosts for S. mansoni have outnumbered those for S. haematobium by a factor of 5--40 in the past 7 years. Changes in the proportions of snail vectors appear to be related to construction of the Aswan High Dam and to changes in the water-flow patterns of the Nile. The change in the relative frequencies of the two infections had important public-health implications, since the hepatosplenic schistosomiasis caused by S. mansoni is more difficult to treat and is associated with more morbidity and mortality than the urinary schistosomiasis caused by S. haematobium.

Entities:  

Mesh:

Year:  1979        PMID: 89343     DOI: 10.1016/s0140-6736(79)90249-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

1.  Encouraging innovation, unintended consequences, and group-level research.

Authors:  Robert L Williams; Kurt Stange; William R Phillips; Louise S Acheson; Bijal Balasubramanian; Elizabeth A Bayliss; Robert L Ferrer; James M Gill
Journal:  Ann Fam Med       Date:  2013 May-Jun       Impact factor: 5.166

2.  Selective population chemotherapy among schoolchildren in Beheira governorate: the UNICEF/Arab Republic of Egypt/WHO Schistosomiasis Control Project.

Authors:  A el Malatawy; A el Habashy; N Lechine; H Dixon; A Davis; K E Mott
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

3.  Water level regulation and control of schistosomiasis transmission: a case study in Oyan Reservoir, Ogun State, Nigeria.

Authors:  I E Ofoezie; S O Asaolu
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  Changes in human schistosomiasis levels after the construction of two large hydroelectric dams in central Côte d'Ivoire.

Authors:  E K N'Goran; S Diabate; J Utzinger; B Sellin
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 5.  Water-based interventions for schistosomiasis control.

Authors:  William Evan Secor
Journal:  Pathog Glob Health       Date:  2014-07       Impact factor: 2.894

6.  Endomyocardial fibrosis in Egypt: an illustrated review.

Authors:  M A Rashwan; M Ayman; S Ashour; M M Hassanin; A A Zeina
Journal:  Br Heart J       Date:  1995-03

Review 7.  Biomphalaria alexandrina in Egypt: past, present and future.

Authors:  Iman F Abou-El-Naga
Journal:  J Biosci       Date:  2013-09       Impact factor: 1.826

8.  Can human schistosomiasis mansoni control be sustained in high-risk transmission foci in Egypt?

Authors:  Hala Elmorshedy; Robert Bergquist; Nadia Emam Abou El-Ela; Safaa Mohamed Eassa; Elham Elsayed Elsakka; Rashida Barakat
Journal:  Parasit Vectors       Date:  2015-07-16       Impact factor: 3.876

Review 9.  Hepatic and intestinal schistosomiasis: review.

Authors:  Tamer Elbaz; Gamal Esmat
Journal:  J Adv Res       Date:  2013-01-11       Impact factor: 10.479

10.  Geographic clustering of leishmaniasis in northeastern Brazil.

Authors:  Albert Schriefer; Luiz H Guimarães; Paulo R L Machado; Marcus Lessa; Hélio A Lessa; Ednaldo Lago; Guilherme Ritt; Aristóteles Góes-Neto; Ana L F Schriefer; Lee W Riley; Edgar M Carvalho
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.